Next Article in Journal
Tailoring Apixaban in Nanostructured Lipid Carrier Enhancing Its Oral Bioavailability and Anticoagulant Activity
Next Article in Special Issue
Infant Exposure to Antituberculosis Drugs via Breast Milk and Assessment of Potential Adverse Effects in Breastfed Infants: Critical Review of Data
Previous Article in Journal
Enhanced Immunomodulation, Anti-Apoptosis, and Improved Tear Dynamics of (PEG)-BHD1028, a Novel Adiponectin Receptor Agonist Peptide, for Treating Dry Eye Disease
Previous Article in Special Issue
Determination of the Pharmacokinetics and Pharmacodynamics of Isoniazid, Rifampicin, Pyrazinamide and Ethambutol in a Cross-Over Cynomolgus Macaque Model of Mycobacterium tuberculosis Infection
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(1), 79; https://doi.org/10.3390/pharmaceutics15010079
Action Date Notes Link
article pdf uploaded. 26 December 2022 16:33 CET Version of Record https://www.mdpi.com/1999-4923/15/1/79/pdf-vor
article xml file uploaded 11 January 2023 03:59 CET Original file -
article xml uploaded. 11 January 2023 03:59 CET Update https://www.mdpi.com/1999-4923/15/1/79/xml
article pdf uploaded. 11 January 2023 03:59 CET Updated version of record https://www.mdpi.com/1999-4923/15/1/79/pdf
article html file updated 11 January 2023 04:00 CET Original file -
article html file updated 1 March 2023 06:16 CET Update -
article html file updated 5 March 2023 00:46 CET Update https://www.mdpi.com/1999-4923/15/1/79/html
Back to TopTop